ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

NCI-Approved Clinical Trials

July 30, 2010

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009

Receipt Dates Clarified For AIDS-Cancers PA

July 4, 1997